Correlation of Ultrasound and MRI Measurements of Quadratus Femoris Thickness and Ischiofemoral Distance in Clinically and Radiologically Diagnosed Ischiofemoral Impingement
CompletedNCT07198646
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this observational study is to evaluate the correlation between ultrasound measurements of quadratus femoris muscle thickness and ischiofemoral distance, as well as clinical parameters, with MRI measurements in patients diagnosed with ischiofemoral impingement (IFI) through MRI imaging and clinical examination. The main questions it aims to answer are: Is there a correlation between ultrasound and MRI measurements of quadratus femoris muscle thickness and ischiofemoral distance in patients with clinically and radiologically confirmed IFI? How do clinical parameters relate to ultrasound and MRI findings in these patients? What is the intra- and inter-rater reliability of ultrasound measurements for these parameters? Participants will undergo ultrasound measurement of quadratus femoris muscle thickness and ischiofemoral distance, assessment of clinical parameters related to ischiofemoral impingement, and measurements performed twice by two independent raters to assess intra- and inter-rater reliability. Researchers will compare ultrasound and MRI measurements as well as clinical parameters to determine if ultrasound can serve as a reliable and cost-effective alternative for diagnosing ischiofemoral impingement.
Study details
- Official title
- Evaluation of the Correlation of Ultrasound Measurements of Quadratus Femoris Muscle Thickness and Ischiofemoral Distance With MR Measurements in Patients Diagnosed With Ischiofemoral Impingement by MR Imaging and Clinical Examination.
- Conditions
- Hip Pain Chronic
- Impingement Syndrome
- Sponsor
- Kutay Can ÇAMLICA
- Organization
- Sisli Hamidiye Etfal Training and Research Hospital
- Start date
- 2024-10-10
- Primary completion
- 2025-03-10
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Patients older than 18 years and younger than 65 years. 2. Patients diagnosed by MRI 3. Those with a body mass index below 25 kg/m2 4. those with hip pain or positive physical examination tests Exclusion Criteria: 1. Sciatic nerve damage detected on EMG 2. Patients with operative ischiofemoral decompression 3. Corticosteroid or any injection to the hip in the last 3 months 4. History of peripheral nerve damage 5. Femoroacetabular impingement 6. Pregnancy 7. Malignancy 8. Inflammatory pathologies: rheumatic, septic 9. Coxarthrosis-Kelgren-Lawrence grade 3-4 10. Those who have undergone hip arthroplasty/surgery 11. Causes of lumbar radiculopathy, spondylolisthesis 12. Patients with increased femoral anteversion - patients with increased hip internal rotation (Toe-in)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07198646